Customer Support: +44 (0)203 327 3140

Your region & currency

United Kingdom English(GB)

Pricing in GBP £

Local sites

  • Shopping Cart
    There are no items in your cart

We noticed you are browsing from United States. Switch to our United States site for local pricing in USD.

Dismiss alert

BS EN ISO 10993-3:2014

Superseded

Superseded

View Superseded by

Biological evaluation of medical devices Tests for genotoxicity, carcinogenicity and reproductive toxicity

Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

31-10-2014

Superseded date

09-09-2026

Superseded by

BS EN ISO 10993-3:2026

£306.00
Excluding VAT
Summarise this standard

Foreword
Introduction
1 Scope
2 Normative references
3 Terms and definitions
4 Requirements for test strategies
5 Genotoxicity tests
6 Carcinogenicity tests
7 Reproductive and developmental toxicity tests
8 Test report
Annex A (informative) - Guidance on selecting an appropriate
        sample preparation procedure in genotoxicity testing
Annex B (informative) - Flowchart for follow-up evaluation
Annex C (informative) - Rationale of test systems
Annex D (informative) - Cell transformation test systems
Annex E (normative) - Considerations for carcinogenicity studies
        performed as implantation studies
Annex F (informative) - In vitro tests for embryo toxicity
Bibliography
Annex ZA (informative) - Relationship between this
         European Standard and the Essential
         Requirements of EU Directive 93/42 EEC
         on medical devices
Annex ZB (informative) - Relationship between this
         European Standard and the Essential
         Requirements of EU Directive 90/385/EEC on
         active implantable medical devices

Describes strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices: - genotoxicity - carcinogenicity, - reproductive and developmental toxicity.

Committee
CH/194
DevelopmentNote
Supersedes BS EN 30993-3 and 00/561676 DC. (11/2003) Supersedes 11/30212473 DC. (10/2014)
DocumentType
Standard
Pages
48
PublisherName
British Standards Institution
Status
Superseded
SupersededBy
Supersedes

This part of ISO10993 specifies strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices:

  • genotoxicity;

  • carcinogenicity;

  • reproductive and developmental toxicity.

This part of ISO10993 is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, or reproductive toxicity has been established.

NOTE Guidance on selection of tests is provided in ISO10993-1.

⚠

A newer version of this standard is available.

View Current Edition
£306.00
Excluding VAT